异动解读 | 腾盛博药-B股价盘中暴跌7.41%,业绩下滑及机构评级持有或是主因

异动解读
19 Nov 2024

腾盛博药-B(02137)今日盘中股价暴跌7.41%,引发市场高度关注。

资料显示,该公司最新财报数据不佳,净利润录得-3.07亿港元,每股亏损0.42港元。另外,虽然1家参与评级的机构100%给予持有评级,但缺乏买入评级,或令投资者对公司前景信心不足。

虽然公司在传染病及中枢神经系统疾病治疗领域仍有一定增长潜力,但短期面临业绩下滑及机构评级不利的双重压力,或是导致其股价暴跌的主因。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10